We provide state-of-the-art (multi-)omics solutions and unbiased approaches
Single cell omics
Single-cell omics analyzes omics data (like genomics or transcriptomics) at the individual cell level. This reveals heterogeneity within cell populations. It provides a detailed view of complex biological processes and allows to explore cell-specific therapy responses.
Supported by our sister unit OHMX.bio
Proteomics
Proteomics identifies and quantifies proteins, including post-translational modifications, using high-resolution MS technology. This approach is ideal for broad protein biomarker discovery, interaction or deep proteomic profiling. Sequencing-based alternatives are also available for more focused discovery and validation efforts.
Supported by our sister unit OHMX.bio
Translatomics
Ribosome profiling is a high-throughput omics approach that maps ribosome-protected mRNA fragments, providing a snapshot of active translation. It enables precise measurement of protein synthesis rates, identification of novel translation events, and analysis of translational regulation and is applicable within disease research, and drug development.
Supported by our sister unit OHMX.bio
Transcriptomics
Transcriptomics (qPCR or RNA sequencing) is a powerful tool to understand gene expression patterns and how they shift in response to disease or treatment. These approaches are critical to get insights into pathways and mechanisms of action.
Supported by our sister unit OHMX.bio
Epigenomics
Epigenetic sequencing investigates chemical modifications to DNA and RNA that influence gene activity without altering the underlying genetic code. These modifications play a crucial role in development, disease (cancer) mechanisms, and therapeutic responses.
Supported by our sister unit OHMX.bio
Genomics
Genomics enables researchers to identify genetic variations, structural changes, and mutations that underpin disease mechanisms. Whether applied to oncology or rare genetic disorders, these insights provide a foundation for biomarker discovery and targeted therapies.
